Clay Siegall Email
CEO/President/Chairman . Seattle Genetics
How to contact Clay Siegall
Join and see Clay's contact info for free!Current Roles
Employees:
4244Revenue:
$1.8BAbout
Seattle Genetics discovers and develops monoclonal antibody, or mAb-based therapeutics to treat cancer and related diseases. The company has four technologies: engineered mAbs, mAb-drug conjugates,single-chain immunotoxins and ADEPT. We have built a strong corporate culture around the values of integrity, scientific excellence, teamwork, innovation and mutual respect. Seattle Genetics embodies an entrepreneurial spirit that advances breakthrough therapies, which is why we are an acknowledged leader today in antibody-drug conjugate technology.Seattle Genetics Address
21823 30th Dr SEBothell, WA
United States